Nanotechnology To Improve The Performance Of Your Small And Large Molecule Medicines

Nanotechnology has been viewed as a very promising approach to enable delivery of complex oral and inhaled therapies. Now, Nanoform is making that promise a reality not only for those, but also for additional delivery routes like long-acting injectables, ophthalmic medicines, and hydrogels across both small molecules and biologics. Nanoform has built out best-in-class nanotechnology to design some of the world’s smallest amorphous and crystalline nanoparticles, formulate them into superior dose forms, and scale up to GMP supply.

Christian Jones, the Chief Commercial Officer at Nanoform, will bring us up-to-date on latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations through superior bioavailability, drug loading, route of administration, pill burden, and more. Christian has over 20 years of experience in drug discovery, development and delivery from industry leaders such as Johnson Matthey, Dr. Reddy’s, Prosonix, and Tripos.